Plain-English translation of NCT07623265 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is collecting tumor tissue and blood samples from people with liver cancer to understand how the immune system works in this disease. Researchers will examine these samples using advanced laboratory techniques to identify patterns that could help predict which patients will benefit most from immunotherapy treatments. The goal is to improve how doctors use immunotherapy to treat liver cancer more effectively.
Currently, not all patients with liver cancer respond equally well to immunotherapy treatments. By studying the immune system's behavior in tumor tissue and blood, researchers hope to discover biological markers that can help doctors identify which patients are most likely to benefit from this treatment and develop better, more personalized approaches to care.
You likely qualify if…
You likely don't qualify if…
Participation involves donating tumor tissue samples that are collected during your standard medical procedures (such as biopsies or surgery) and blood samples taken during routine lab visits—no extra procedures or study visits are required. For some participants, the study uses leftover tissue from previous biopsies or surgical specimens. The researchers will track your medical information and treatment outcomes over time to understand how your immune system responds to treatment.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Belgium